Literature DB >> 20620431

Megakaryopoiesis.

Amy E Geddis1.   

Abstract

The process of megakaryopoiesis and platelet production is complex, with the potential for regulation at multiple stages. Megakaryocytes are derived from the hematopoietic stem cell through successive lineage commitment steps, and they undergo a unique maturation process that includes polyploidization, development of an extensive internal demarcation membrane system, and finally formation of pro-platelet processes. Platelets are shed from these processes into vascular sinusoids within the bone marrow. Megakaryocyte differentiation is regulated both positively and negatively by transcription factors and cytokine signaling. Thrombopoietin (TPO) is the most important hematopoietic cytokine for platelet production. Clinically, acquired and inherited mutations affecting megakaryocytic transcription factors and thrombopoietin signaling have been identified in disorders of thrombocytopenia and thrombocytosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20620431      PMCID: PMC2904992          DOI: 10.1053/j.seminhematol.2010.03.001

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  94 in total

1.  Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release.

Authors:  Gianfranco Mattia; Francesca Vulcano; Luisa Milazzo; Alessandra Barca; Giampiero Macioce; Adele Giampaolo; H Jane Hassan
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

2.  Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways.

Authors:  Keita Kirito; Tomoko Watanabe; Ken-ichi Sawada; Hitoshi Endo; Keiya Ozawa; Norio Komatsu
Journal:  J Biol Chem       Date:  2001-12-27       Impact factor: 5.157

Review 3.  Thrombopoietin: a pan-hematopoietic cytokine.

Authors:  Amy E Geddis; Hannah M Linden; Kenneth Kaushansky
Journal:  Cytokine Growth Factor Rev       Date:  2002-02       Impact factor: 7.638

Review 4.  Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade.

Authors:  J Avruch; A Khokhlatchev; J M Kyriakis; Z Luo; G Tzivion; D Vavvas; X F Zhang
Journal:  Recent Prog Horm Res       Date:  2001

5.  Phosphatidylinositol 3-kinase is necessary but not sufficient for thrombopoietin-induced proliferation in engineered Mpl-bearing cell lines as well as in primary megakaryocytic progenitors.

Authors:  A E Geddis; N E Fox; K Kaushansky
Journal:  J Biol Chem       Date:  2001-06-20       Impact factor: 5.157

6.  Thrombopoietin induces phosphoinositol 3-kinase activation through SHP2, Gab, and insulin receptor substrate proteins in BAF3 cells and primary murine megakaryocytes.

Authors:  Y Miyakawa; P Rojnuckarin; T Habib; K Kaushansky
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

7.  c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia.

Authors:  M Ballmaier; M Germeshausen; H Schulze; K Cherkaoui; S Lang; A Gaudig; S Krukemeier; M Eilers; G Strauss; K Welte
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

8.  Interferon-alpha directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1.

Authors:  Q Wang; Y Miyakawa; N Fox; K Kaushansky
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

9.  Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor.

Authors:  D D Spyropoulos; P N Pharr; K R Lavenburg; P Jackers; T S Papas; M Ogawa; D K Watson
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

10.  Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1- and Rap1-B-Raf-dependent pathways.

Authors:  J Garcia; J de Gunzburg; A Eychène; S Gisselbrecht; F Porteu
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

View more
  32 in total

Review 1.  Towards the Manufacture of Megakaryocytes and Platelets for Clinical Application.

Authors:  Anja Baigger; Rainer Blasczyk; Constanca Figueiredo
Journal:  Transfus Med Hemother       Date:  2017-05-23       Impact factor: 3.747

2.  The Hippo-p53 pathway in megakaryopoiesis.

Authors:  Praveen K Suraneni; John D Crispino
Journal:  Haematologica       Date:  2016-12       Impact factor: 9.941

3.  PMA induces SnoN proteolysis and CD61 expression through an autocrine mechanism.

Authors:  Chonghua Li; Natoya Peart; Zhenyu Xuan; Dorothy E Lewis; Yang Xia; Jianping Jin
Journal:  Cell Signal       Date:  2014-03-15       Impact factor: 4.315

4.  Carboxyl-terminal-dependent recruitment of nonmuscle myosin II to megakaryocyte contractile ring during polyploidization.

Authors:  Idinath Badirou; Jiajia Pan; Céline Legrand; Aibing Wang; Larissa Lordier; Siham Boukour; Anita Roy; William Vainchenker; Yunhua Chang
Journal:  Blood       Date:  2014-09-02       Impact factor: 22.113

5.  JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation.

Authors:  Rodolphe Besancenot; Damien Roos-Weil; Carole Tonetti; Hadjer Abdelouahab; Catherine Lacout; Florence Pasquier; Christophe Willekens; Philippe Rameau; Yann Lecluse; Jean-Baptiste Micol; Stefan N Constantinescu; William Vainchenker; Eric Solary; Stéphane Giraudier
Journal:  Blood       Date:  2014-08-20       Impact factor: 22.113

6.  Label free monitoring of megakaryocytic development and proplatelet formation in vitro.

Authors:  Dimitra Pouli; Lorenzo Tozzi; Carlo A Alonzo; Zhiyi Liu; David L Kaplan; Alessandra Balduini; Irene Georgakoudi
Journal:  Biomed Opt Express       Date:  2017-09-27       Impact factor: 3.732

7.  RUNX1-induced silencing of non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploidization.

Authors:  Larissa Lordier; Dominique Bluteau; Abdelali Jalil; Céline Legrand; Jiajia Pan; Philippe Rameau; Dima Jouni; Olivier Bluteau; Thomas Mercher; Catherine Leon; Christian Gachet; Najet Debili; William Vainchenker; Hana Raslova; Yunhua Chang
Journal:  Nat Commun       Date:  2012-03-06       Impact factor: 14.919

Review 8.  Mouse models of diseases of megakaryocyte and platelet homeostasis.

Authors:  Catherine L Carmichael; Warren S Alexander
Journal:  Mamm Genome       Date:  2011-06-11       Impact factor: 2.957

Review 9.  Megakaryocytes, malignancy and bone marrow vascular niches.

Authors:  B Psaila; D Lyden; I Roberts
Journal:  J Thromb Haemost       Date:  2012-02       Impact factor: 5.824

10.  Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line.

Authors:  Keiichi Tozawa; Yukako Ono-Uruga; Masaki Yazawa; Taisuke Mori; Mitsuru Murata; Shinichiro Okamoto; Yasuo Ikeda; Yumiko Matsubara
Journal:  Blood       Date:  2018-11-28       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.